VIR Vir Biotechnology, Inc.

NEUTRAL Impact: 3/10 8-K
Horizon months Filed Mar 4, 2026 Processed 3mo ago SEC 0001193125-26-091447
8-K context-dependent: Items 5.02
Final — all horizons settled through T+60d
VIR ▼ -0.77% at T+60d
NEUTRAL call ✗ call lost -0.77% · α vs SPY -12.07% · entry $9.10 → $9.03
Last close $8.45 (close Jun 8) · -7.14% from $9.10 entry
Entry anchored
Mar 4, 03:59 PM ET
via Databento tick
T+1d
+4.95%
call +4.95% · α +6.26%
$9.55
settled 3mo ago
T+5d
+4.18%
call +4.18% · α +6.41%
$9.48
settled 3mo ago
T+20d
-0.44%
call -0.44% · α +3.35%
$9.06
settled 2mo ago
T+60d
-0.77%
call -0.77% · α -12.07%
$9.03
settled 12d ago

Price Chart

Loading chart...

Executive Summary

Vir Biotechnology appointed CEO Marianne De Backer to the additional role of President. This is an internal leadership expansion with no immediate financial impact or executive departure.

Actionable Insight

Monitor for any future disclosures regarding changes in executive compensation or strategic direction that may result from the expanded role. No trading action warranted based on this filing alone.

Key Facts

  • Marianne De Backer, current CEO and principal executive officer, was appointed to the additional role of President on March 4, 2026
  • No executive departures were reported
  • No compensation details were disclosed in the filing
  • The appointment reflects a consolidation of leadership roles under the existing CEO

Financial Impact

No immediate financial impact disclosed

executive leadershipgovernance

Risk Factors

  • Potential concentration of power in a single executive without checks and balances
  • Lack of disclosed succession planning if De Backer holds both CEO and President roles

Market Snapshot

Exchange
Nasdaq

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001193125-26-091447
Document: 0001193125-26-091447-index-headers.html0001193125-26-091447
Document: 0001193125-26-091447-index.html0001193125-26-091447
Document: 0001193125-26-091447.txt0001193125-26-091447
12 reports for VIR
Performance horizon
25% Hit rate 1 of 4 directional calls best @ T+60▲ +10.12%Feb 24, 2026
Filters
Rows
Reports for VIR — sortable, filterable
Type Now
Jun 2, 2026
7d ago
Insider Cluster
NEUTRAL ★ 2/10
$8.77 $9.15▲ +4.33%▲ +3.93%$8.45 (−3.65%)
May 28, 2026
12d ago
8-K
NEUTRAL ★ 2/10
$9.55 $9.54▼ −0.10%▼ −0.34%$8.45 (−11.52%)
Apr 16, 2026
7w ago
DEFA14A
NEUTRAL ★ 3/10
$10.33 $10.75▲ +4.07%▲ +2.85%$8.45 (−18.20%)
Apr 10, 2026
8w ago
8-K
NEUTRAL ★ 3/10
$9.31 $10.05▲ +7.95%▲ +6.74%$8.45 (−9.24%)
Apr 1, 2026
10w ago
Insider Cluster
BEARISH ★ 6/10
$9.02 $9.06▼ −0.44%▼ −0.36%$8.45 (+6.32%)
Mar 4, 2026
13w ago
8-K
NEUTRAL ★ 3/10
$9.10 $9.55▲ +4.95%▲ +6.26%$8.45 (−7.14%)
Feb 24, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$9.49 $10.00▼ −5.37%▼ −4.54%$8.45 (+10.96%)
Feb 23, 2026
15w ago
Insider Cluster
BEARISH ★ 5/10
$7.43 $9.49▼ −27.73%▼ −26.99%$8.45 (−13.73%)
Feb 23, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$7.43 $9.49▲ +27.73%▲ +26.99%$8.45 (+13.73%)
Feb 23, 2026
15w ago
Insider Cluster
NEUTRAL ★ 4/10
$7.43 $9.49▲ +27.73%▲ +26.99%$8.45 (+13.73%)
Showing 10 of 12

US Market Status

Market Closed — Opens in 5h 26m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access